SC
ARCT icon

Steven Cohen’s Arcturus Therapeutics ARCT Stock Holding History

Steven Cohen’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
231,582
+167,737
+263% +$1.32M ﹤0.01% 2550
2026
Q1 		$493K Sell
63,845
-158,318
-71% -$1.16M ﹤0.01% 3125
2025
Q4 		$1.36M Buy
+222,163
New +$2.4M ﹤0.01% 2704
2025
Q3 		– Sell
-6,154
Closed -$80.1K – 2299
2025
Q2 		$80.1K Sell
6,154
-4,163
-40% -$49.2K ﹤0.01% 2082
2025
Q1 		$109K Buy
+10,317
New +$164K ﹤0.01% 1906
2024
Q3 		– Sell
-244,154
Closed -$5.95M – 1962
2024
Q2 		$5.95M Sell
244,154
-91,224
-27% -$2.77M 0.02% 789
2024
Q1 		$11.3M Buy
335,378
+317,800
+1,808% +$11.3M 0.03% 670
2023
Q4 		$554K Sell
17,578
-317,700
-95% -$7.55M ﹤0.01% 1553
2023
Q3 		$8.57M Buy
335,278
+330,875
+7,515% +$10.2M 0.03% 708
2023
Q2 		$126K Sell
4,403
-75,985
-95% -$2.07M ﹤0.01% 1503
2023
Q1 		$1.93M Buy
80,388
+15,888
+25% +$285K 0.01% 985
2022
Q4 		$1.09M Sell
64,500
-552,624
-90% -$9.64M ﹤0.01% 1033
2022
Q3 		$9.15M Sell
617,124
-296,199
-32% -$4.97M 0.04% 530
2022
Q2 		$14.4M Buy
913,323
+488,123
+115% +$9.58M 0.06% 399
2022
Q1 		$11.5M Buy
+425,200
New +$10.9M 0.05% 473
2020
Q3 		– Sell
-223,013
Closed -$10.4M – 913
2020
Q2 		$10.4M Buy
+223,013
New +$7.69M 0.07% 327

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Steven Cohen's ARCT Position: Q2 2026 in Review

Steven Cohen increased its Arcturus Therapeutics (ARCT) stake by 263% in Q2 2026, buying an estimated $1.32M and bringing the position to 231,582 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2550.

Steven Cohen first reported a position in ARCT in Q2 2020 and has held it in 16 quarters since. The position peaked at $14.4M in Q2 2022. 133 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Steven Cohen held 231,582 shares of Arcturus Therapeutics worth $1.56M as of Q2 2026.
  • Steven Cohen bought 167,737 Arcturus Therapeutics shares in Q2 2026, an estimated $1.32M.
  • Arcturus Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2550 holding.
  • Steven Cohen first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • Steven Cohen's Arcturus Therapeutics position peaked at $14.4M in Q2 2022.
  • 133 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.